- Hikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drugPlus, news about West Pharmaceutical, Stallergenes Greer and Curium: 🏭 Hikma’s US expansion: The generic drugmaker is investing $267 million in Ohio. Its existing factory in Columbus will get $2…Endpoints · 1mo ago↗ source
- Lilly, Boehringer retrench in Germany on proposed health spending cutsBacklash is brewing against a sweeping overhaul of Germany’s health insurance system as Eli Lilly and Boehringer Ingelheim slash investment in the country. The drugmakers' cuts come after the Ger…Endpoints · 1mo ago↗ source
- Supreme Court sides with Hikma in 'skinny label' caseThe Supreme Court unanimously sided with Hikma Pharmaceuticals and its “skinny label” version of a prescription-strength fish oil pill in a case that was closely watched by the generics industry.…